J Med Chem 64(15):1118311194 Lau DCW et al (2021) Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
For most researchers, GHK-Cu is the better comparison baseline
Many people will tolerate nausea, for example
They can also suppress appetite even further, making it harder to meet protein and nutrient needs a challenge already posed by these medications
This inflammatory cascade is a significant contributor to the mood disturbances, depression, and anxiety frequently seen in these patient populations, a topic we explore deeply in our article on Long COVID and Mental Health